Why Post-Birth DNA Verification Matters in Colombia Surrogacy
Quick Answer
A recent international surrogacy case has drawn attention to one of the most serious risks in assisted reproduction: what happens if a child born through surrogacy is not genetically related to the intended parent as expected?
In Colombia, DNA testing is commonly used during the post-birth legal and documentation process to establish a biological connection between the baby and at least one intended parent. Although Colombia does not yet have a single national surrogacy statute requiring identical procedures in every case, this genetic verification can provide an important safeguard before the child’s parentage documents and international travel arrangements are finalized.
For intended parents, the lesson is clear: a successful pregnancy and delivery are not enough. Every international surrogacy program should include a documented process for confirming the child’s genetic identity.
A Surrogacy Birth Does Not Automatically Prove Genetic Parentage
In gestational surrogacy, an embryo is created through IVF and transferred to a gestational carrier who is not intended to be genetically related to the baby.
The embryo may be created using:
- the intended father’s sperm and an egg donor;
- the intended parents’ own eggs and sperm;
- donor sperm and an intended mother’s eggs;
- or donated embryos.
Throughout the pregnancy, ultrasound examinations can confirm fetal growth, anatomy and well-being. However, an ultrasound cannot confirm whose egg or sperm created the pregnancy.
That question can only be answered through genetic testing.
This distinction is extremely important. A normal pregnancy and a healthy delivery do not, by themselves, prove that the correct embryo was transferred or that the newborn has the expected biological relationship with the intended family.
How DNA Testing Is Used After a Surrogacy Birth in Colombia
Colombia currently regulates surrogacy primarily through constitutional principles, court decisions and post-birth legal procedures rather than through one comprehensive national surrogacy law.
In many Colombia surrogacy cases, the gestational carrier is initially recognized in the birth documentation because she gave birth to the child. The intended family must then complete additional legal steps to establish or modify parentage.
DNA evidence is commonly used during this process to demonstrate that the child is biologically related to at least one intended parent. This evidence may support:
- recognition of the biological father;
- civil birth-registration procedures;
- court proceedings concerning parentage;
- removal or replacement of the gestational carrier’s name where legally permitted;
- citizenship and passport applications;
- and the child’s eventual departure from Colombia.
Colombia’s Constitutional Court has repeatedly addressed the difficulties surrounding birth registration, nationality and parentage in surrogacy cases, demonstrating that genetic connection can become central to the legal analysis.
Could DNA Testing Detect an Embryo or Parentage Error?
Yes.
A properly conducted post-birth DNA test can determine whether the baby has the expected biological relationship with the tested intended parent.
For example, when an intended father’s sperm was supposed to be used, testing the newborn and the intended father can confirm or exclude that relationship.
This means that a serious discrepancy may be discovered while the child and intended parents are still in Colombia and before the family completes:
- final parentage documentation;
- citizenship applications;
- passport issuance;
- and international travel.
DNA testing does not prevent every possible laboratory or reproductive error. However, it creates an important final checkpoint.
Without that checkpoint, an unexpected genetic relationship might remain undiscovered until the family voluntarily orders testing months or years later.
Does Colombia Test Both the Sperm Provider and the Egg Provider?
Not necessarily.
This is an important distinction for intended parents to understand.
Colombian post-birth procedures often focus on proving a biological link between the baby and at least one intended parent. When an anonymous egg donor is used, the donor may not participate in post-birth testing, and her identity may be protected under the clinic’s donor procedures.
Therefore, a paternity test confirming the intended father’s relationship can establish that his sperm was used, but it does not by itself confirm the identity of the egg provider.
A comprehensive risk-management system may require several separate controls:
- Laboratory witnessing and identification during IVF
- Traceable embryo records
- Donor identity and consent documentation
- Chain-of-custody records
- Post-birth DNA confirmation with the intended genetic parent
- Additional testing when a discrepancy or reasonable concern exists
DNA testing should therefore be viewed as one part of a wider quality-control system, not as a substitute for proper embryology laboratory procedures.
Why Mexico and Colombia Should Not Be Treated as Identical
Mexico does not have one uniform national surrogacy framework. Rules and legal procedures may differ by state, hospital, civil registry and court.
In some Mexican cases, intended parents may obtain birth documentation through a judicial or civil-registration process without an automatic DNA test being required at the moment of birth. For children seeking U.S. citizenship, a consular officer may later request DNA evidence, but the U.S. Embassy states that such testing is discretionary rather than universally mandatory.
This can create an important practical difference.
Where DNA testing is not built into the immediate post-birth process, a child may receive local documentation and leave the hospital before the intended family has independently confirmed the expected genetic relationship.
By contrast, Colombia’s reliance on post-birth biological-parentage evidence means that DNA verification is more commonly integrated into the legal pathway for international intended parents.
This does not make every Colombia program risk-free, nor does it mean every Mexico program lacks safeguards. It means intended parents must examine the actual procedures used by the clinic, agency, lawyers, hospital and civil authorities—not simply the country named in the marketing materials.
What Intended Parents Should Ask Before Signing a Colombia Surrogacy Agreement
Before beginning a Colombia surrogacy journey, intended parents should ask the clinic and legal team:
- Will a post-birth DNA test be performed?
- Which intended parent will be tested?
- Who collects the samples?
- Is the laboratory independent and accredited?
- How is chain of custody documented?
- When will the results be available?
- Can parentage documents proceed before results are received?
- What happens if the expected genetic relationship is not confirmed?
- Who pays for additional testing?
- Are the embryo, sperm and donor records preserved?
- Does the contract establish a formal investigation procedure?
These questions should be answered before embryo transfer—not after the baby is born.
DNA Testing Is a Safeguard, Not an Admission of Distrust
Some families may feel that requesting DNA testing suggests they do not trust the clinic or gestational carrier.
That is not the right way to understand it.
DNA verification is comparable to checking a patient’s name before a medical procedure or confirming an infant’s identification before hospital discharge. It is a routine safety measure designed to protect:
- the child;
- the intended parents;
- the gestational carrier;
- the fertility clinic;
- and the legal integrity of the entire process.
Responsible programs should not resist independent verification. They should welcome it as evidence that the program is prepared to stand behind its medical and legal records.
What Happens If the DNA Result Is Unexpected?
An unexpected DNA result does not automatically reveal how the pregnancy occurred.
Several possibilities may need to be investigated, including:
- specimen or testing error;
- incorrect sample collection;
- chain-of-custody problems;
- documentation errors;
- use of the wrong sperm or embryo;
- embryo misidentification;
- or a pregnancy that did not result from the recorded embryo transfer.
No conclusion should be reached before repeat testing and a full medical, laboratory and legal investigation.
The immediate priority should be the child’s safety and legal protection. The family should obtain independent counsel, preserve all records and ensure that no party makes unsupported public allegations before the facts are established.
The Canbaby Surrogacy Perspective
At Canbaby Surrogacy, we believe a live birth should never be treated as the final proof that an international fertility program was completed correctly.
The real standard should include three separate outcomes:
- a healthy baby;
- a safely supported gestational carrier;
- and verified genetic and legal parentage.
As an embryologist-led international team, we understand that IVF safety begins long before embryo transfer. It depends on correct patient identification, reliable laboratory witnessing, accurate sperm and egg records, embryo traceability and clear communication among the clinic, agency and legal team.
Post-birth DNA testing provides one final layer of protection.
It cannot replace good laboratory practice, but it can help identify a serious discrepancy before the child leaves Colombia and before the intended family completes the international legal process.
For intended parents comparing Colombia surrogacy programs, price and pregnancy guarantees should not be the only questions.
They should also ask:
How will the program prove that the baby born is genetically related to the intended family exactly as planned?
A trustworthy program should have a clear answer.
